Product Description: Guanosine triphosphate-13C10,15N5 (tetraammonium) is the 13C and 15N labeled Guanosine triphosphate tetraammonium[1]. Guanosine triphosphate is a native nucleotide. The derivatives of GTP may be used as specific inhibitors against COVID-19[2].
Applications: Metabolism-protein/nucleotide metabolism
Formula: 13C10H28N4 15N5O14P3
References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216./[2]Abdo A Elfiky, et al. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci. 2020 May 1;248:117477.
Molecular Weight: 606.20
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: DNA/RNA Synthesis;Endogenous Metabolite;Nucleoside Antimetabolite/Analog;SARS-CoV